UK General Election 2024 - Read our five key asks of the next government full report and executive summary
 
 
 
 
 
 

Addressing the global challenge of multimorbidity

  • *Mandatory fields

  • For more information about the wider 'Addressing the global challenge of multimorbidity' policy project, please visit here.

    To submit a response to this project online, please complete the below form. If you would prefer to submit your response in Word, please download the document from the right hand side of this page and return it to [email protected] by Wednesday 30 November.

  • Before answering the questions, please familiarise yourself with the background document available to download from the right hand side of this page or below.

    Addressing the global challenge of multimorbidity - background information

    Download

    Definitions

  • 1There is no standard definition of ‘multimorbidity’ – various different definitions are used. Which definitions (or aspects of definitions) do you think are most helpful to efforts to describe and understand multimorbidity?

    Please provide references for any published research, and highlight any other initiatives related to multimorbidity that the Academy may be interested in.

  • Current knowledge base

    When answering these questions, please consider both national and international populations of high, middle, and low income countries. Please provide examples and case studies to illustrate your arguments where appropriate. Please provide references for any published research.

  • 2What are the key data, and what data sources exist, on the prevalence, burden (including costs and impact on health systems) and determinants of multimorbidity? Are there significant gaps in such data and, if so, what are they?

  • 3What are the key data, and what data sources exist, on the prevention of multimorbidity? Are there significant gaps in such data and, if so, what are they?

  • 4What are the key data, and what data sources exist, on the management of multimorbidity? Are there significant gaps in such data; if so, what are they?

    The term ‘management’ here could refer to clinical interventions designed to specifically treat patients with multimorbidity as well as strategies for the delivery of healthcare services patients with multimorbidity. The term also refers to a wide range of management approaches that may differ by the specific diseases that co-exist.

  • 5What are the key sources of funding for research into multimorbidity? Are there gaps in funding and, if so, where?

  • Looking Forward

  • 6What should the definition of ‘multimorbidity’ be? How would this definition improve research and/or treatment?

  • 7What are the priorities for research about the prevalence, burden and determinants of multimorbidity?

  • 8What are the priorities for research about the prevention of multimorbidity?

  • 9What are the priorities for research about the management (as defined above) of patients with multimorbidity?

  • 10What should be the strategic response of both national and international research funders and agencies be to multimorbidity?

Please click 'next' to review your response before submitting it.

Meet the President - June 2024 (Online)

Book Now

Meet the President - Manchester

Book Now

Meet the President - Cambridge

Book Now
View more
 
 
 
 
 
 
FB Twitter Instagram Youtube